<DOC>
	<DOCNO>NCT01339832</DOCNO>
	<brief_summary>This observational study follow-up study protocol ML18280 . Survival data patient take part conclude study ML18280 collect 5 year LPLV ML18270 .</brief_summary>
	<brief_title>An Observational Study Xeloda ( Capecitabine ) Oxaliplatin Prior Concurrent To Preoperative Pelvic Radiotherapy Patients With Locally Advanced Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients take part conclude study ML18280 accord protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>